Retatrutide Dosage Calculator
Calculate exact retatrutide injection volumes for any dose. Uses standard reconstitution formulas — pre-filled for a 10mg vial.
Dose Reference Table
Pre-calculated for a 10mg vial + 2ml BAC water = 5,000 mcg/ml concentration. Using a 100-unit (1ml) insulin syringe.
| Dose | Inject Volume (ml) | Syringe Units |
|---|---|---|
| 1000mcg (1mg) | 0.200 ml | 20 units |
| 2000mcg (2mg) | 0.400 ml | 40 units |
| 2500mcg (2.5mg) | 0.500 ml | 50 units |
| 3000mcg (3mg) | 0.600 ml | 60 units |
| 4000mcg (4mg) | 0.800 ml | 80 units |
| 5000mcg (5mg) | 1.000 ml | 100 units |
About Retatrutide
Retatrutide (also called "reta") is a next-generation triple agonist peptide under clinical investigation. It targets three key receptors: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors. This triple mechanism is theorized to provide superior metabolic effects compared to dual or single agonists.
For research purposes, retatrutide is typically reconstituted from a lyophilized powder. The most common vial sizes are 5mg, 10mg, and 20mg. When using 2ml of bacteriostatic water per 10mg vial, the resulting concentration is 5,000 mcg/ml — making dosing calculations straightforward.
The half-life of retatrutide is approximately 6 days, which supports once-weekly administration in research protocols. Always consult a qualified healthcare professional before using any research peptide.